130 related articles for article (PubMed ID: 33275483)
1.
Zhao X; Liu R; Miao Z; Ye N; Lu W
J Comput Biol; 2020 Dec; 27(12):e1699-e1713. PubMed ID: 33275483
[TBL] [Abstract][Full Text] [Related]
2.
Chen Z; Hu H
J Comput Biol; 2019 Dec; 26(12):e1487-e1498. PubMed ID: 31841638
[TBL] [Abstract][Full Text] [Related]
3.
J Comput Biol; 2021 Jul; 28(7):744. PubMed ID: 34171961
[No Abstract] [Full Text] [Related]
4. RETRACTED: Autophagy is a pro-survival mechanism in ovarian cancer against the apoptotic effects of euxanthone.
Zhu L; Liu X; Li D; Sun S; Wang Y; Sun X
Biomed Pharmacother; 2018 Jul; 103():708-718. PubMed ID: 29680739
[TBL] [Abstract][Full Text] [Related]
5.
Zhang Z; Sui Y; Luan L; Li B; Qin C
Cancer Biother Radiopharm; 2020 Aug; ():. PubMed ID: 32822247
[No Abstract] [Full Text] [Related]
6. Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs.
Skariyachan S; Gopal D; Chakrabarti S; Kempanna P; Uttarkar A; Muddebihalkar AG; Niranjan V
Comput Biol Med; 2020 Nov; 126():104054. PubMed ID: 33074111
[TBL] [Abstract][Full Text] [Related]
7.
Li Z; Li Z; Zhong Z; Zhou J; Huang S; Zhou W; Xu J
Cancer Biother Radiopharm; 2020 May; ():. PubMed ID: 32456453
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Molecular Characterization and Biological Activity of Interferon-α in Indian Peafowl (Pavo cristatus).
Zhao H; Wang Y; Liu J; Shao Y; Li J; Chai H; Xing M
DNA Cell Biol; 2017 Aug; ():. PubMed ID: 28783371
[TBL] [Abstract][Full Text] [Related]
10. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
11. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
Gil M; Ramil F; AgÍs JA
Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
[TBL] [Abstract][Full Text] [Related]
12. Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics.
Sawant S; Patil R; Khawate M; Zambre V; Shilimkar V; Jagtap S
In Silico Pharmacol; 2021; 9(1):44. PubMed ID: 34306960
[TBL] [Abstract][Full Text] [Related]
13. MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs.
Feng Z; Chen M; Xue Y; Liang T; Chen H; Zhou Y; Nolin TD; Smith RB; Xie XQ
Brief Bioinform; 2021 Mar; 22(2):946-962. PubMed ID: 33078827
[TBL] [Abstract][Full Text] [Related]
14.
Tan Z; Sun Y; Liu M; Xia L; Cao F; Qi Y; Song Y
Cancer Biother Radiopharm; 2020 Dec; 35(10):e826-e838. PubMed ID: 32598178
[No Abstract] [Full Text] [Related]
15. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and simulation studies on SARS-CoV-2 M
Lokhande KB; Doiphode S; Vyas R; Swamy KV
J Biomol Struct Dyn; 2021 Nov; 39(18):7294-7305. PubMed ID: 32815481
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
Pirzada RH; Haseeb M; Batool M; Kim M; Choi S
Cells; 2021 Apr; 10(5):. PubMed ID: 33946869
[TBL] [Abstract][Full Text] [Related]
19.
Potvin N; Hicks M; Kronk R
J Altern Complement Med; 2021 Dec; 27(12):e1156-e1158. PubMed ID: 33902291
[No Abstract] [Full Text] [Related]
20. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
Ancy I; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
